Speakers
Cheryl Iglesia & Alyssa Brown
Speaker Bios
Dr. Cheryl Iglesia is nationally and internationally recognized for advancing surgical techniques in reconstructive pelvic surgery. Among her many roles, Dr. Iglesia is the current Chair of the Pelvic Floor Disorders Network (PFDN) Advisory Board at the National Institute for Child Health and Human Development (NICHD) and is a past chair of both the Committee for Gynecologic Practice at the American Congress of Obstetricians and Gynecologists (ACOG) and the ACOG Patient Education Board. She has served as Program Chair for the Society of Gynecologic Surgeons (SGS) and the American Urogynecologic Society (AUGS) and has also served on the AUGS Board of Directors. Since 2011, Dr. Iglesia is an appointed special governmental employee for the ObGyn Devices Panel at the US FDA. She currently is the 49th President for the Society of Gynecologic Surgeons.
Alyssa Brown, FNP-C, is a nurse practitioner with the National Center for Advanced Pelvic Surgery (NCAPS) at MedStar Health. As a healthcare provider specializing in urogynecology, she sees women for the diagnosis and treatment of all pelvic floor disorders including urinary incontinence, pelvic organ prolapse, recurrent UTIs, atrophic vaginitis, painful bladder syndrome and other pain disorders. Alyssa completed a Master of Science in Nursing at Drexel University, where she studied as a family nurse practitioner and joined MedStar NCAPS upon graduation. Prior to that, she worked as a registered nurse at MedStar Washington Hospital center for 7 years and was recognized as the Nurse of the Year by the 2021 graduating residents in the Department of Ob/Gyn. She received her BSN magna cum laude from Wilkes University. When not advocating for women, Alyssa enjoys spending time with her family, hiking, running and traveling.
Course Description
N/A
Learning Objectives
1. Assess anticholinergic cognitive burden of common overactive bladder medications and updated Beers Criteria
2) List risks and effectiveness of beta 3 agonist therapy
3) Contrast comparative data of bladder botox versus medications, including cost effectiveness
4) Discuss relative risks and benefits of sacral neuromodulation
CEUs Offered: 1 CE / 1 Rx CE
Course Expiration: December 7, 2024